✨ Medicines Distribution Notices




16 OCTOBER

NEW ZEALAND GAZETTE

4027

Consent to the Distribution of a Changed Medicine

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicine which was referred to the Minister of Health under the provisions of section 24 (5) of the Act and is set out in the Schedule hereto:

Schedule

Product:
Aricept

Active Ingredient:
Donepezil hydrochloride 10mg equivalent to 9.12mg donepezil free base

Dosage Form:
Film coated tablet

New Zealand Sponsor:
Pfizer New Zealand Limited

Manufacturer:
Pfizer PGM, Poce Sur Cisse, France

Product:
Aricept

Active Ingredient:
Donepezil hydrochloride 5mg equivalent to 4.56mg donepezil free base

Dosage Form:
Film coated tablet

New Zealand Sponsor:
Pfizer New Zealand Limited

Manufacturer:
Pfizer PGM, Poce Sur Cisse, France

Dated this 12th day of October 2003.

DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on the 6th day of July 2001).

go6850

Consent to the Distribution of a Changed Medicine

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicine which was referred to the Minister of Health under the provisions of section 24 (5) of the Act and is set out in the Schedule hereto:

Schedule

Product:
Vioxx

Active Ingredient:
Rofecoxib 2.5mg/mL

Dosage Form:
Oral suspension

New Zealand Sponsor:
Merck Sharp & Dohme (New Zealand) Limited

Manufacturer:
Merck & Co Inc, Merck West Point, Pennsylvania, United States of America

Product:
Vioxx

Active Ingredient:
Rofecoxib 5mg/mL

Dosage Form:
Oral suspension

New Zealand Sponsor:
Merck Sharp & Dohme (New Zealand) Limited

Manufacturer:
Merck & Co Inc, West Point, Pennsylvania, United States of America

Product:
Vioxx

Active Ingredient:
Rofecoxib 12.5mg

Dosage Form:
Tablet

New Zealand Sponsor:
Merck Sharp & Dohme (New Zealand) Limited

Manufacturers:
Merck and Co, Bo. Sabana Hoyos, Arecibo, Puerto Rico
Merck Sharp and Dohme Australia Pty Limited, South Granville, New South Wales, Australia

Product:
Vioxx

Active Ingredient:
Rofecoxib 25mg

Dosage Form:
Tablet

New Zealand Sponsor:
Merck Sharp & Dohme (New Zealand) Limited

Manufacturers:
Merck and Co, Bo. Sabana Hoyos, Arecibo, Puerto Rico
Merck Sharp and Dohme Australia Pty Limited, South Granville, New South Wales, Australia

Product:
Vioxx

Active Ingredient:
Rofecoxib 50mg

Dosage Form:
Tablet

New Zealand Sponsor:
Merck Sharp & Dohme (New Zealand) Limited

Manufacturers:
Merck and Co, Bo. Sabana Hoyos, Arecibo, Puerto Rico
Merck Sharp and Dohme Australia Pty Limited, South Granville, New South Wales, Australia

Dated this 7th day of October 2003.

DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on the 6th day of July 2001).

go6700



Next Page →



Online Sources for this page:

VUW Te Waharoa PDF NZ Gazette 2003, No 144


Gazette.govt.nz PDF NZ Gazette 2003, No 144





✨ LLM interpretation of page content

πŸ₯ Consent to the Distribution of a Changed Medicine

πŸ₯ Health & Social Welfare
12 October 2003
Medicines, Distribution, Aricept, Donepezil hydrochloride, Pfizer
  • DON MATHESON, Deputy Director-General, Public Health

πŸ₯ Consent to the Distribution of a Changed Medicine

πŸ₯ Health & Social Welfare
7 October 2003
Medicines, Distribution, Vioxx, Rofecoxib, Merck Sharp & Dohme
  • DON MATHESON, Deputy Director-General, Public Health